S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combining cytarabine and daunorubicin
in treating older patients who have acute myeloid leukemia that has not been previously
treated.